Non-Invasive Prenatal Testing. It is a prenatal screening test that involves analyzing cell-free fetal DNA (cffDNA) in the mother's blood to assess the risk of certain chromosomal abnormalities in the fetus. NIPT is a safe and accurate method for detecting genetic conditions during pregnancy without the need for invasive procedures such as amniocentesis or chorionic villus sampling. NIPT has several advantages over traditional prenatal screening methods. It is non-invasive, meaning it carries no risk of miscarriage or harm to the fetus. It also has a higher detection rate and lower false positive rate compared to other screening tests. However, it's important to remember that NIPT is a screening test and not a diagnostic test. In cases where NIPT indicates a high risk of a chromosomal abnormality, further diagnostic testing, such as amniocentesis or chorionic villus sampling, is typically recommended to confirm the diagnosis.
NIPT has primarily been used to screen for common chromosomal abnormalities, but it is also being expanded to screen for additional genetic conditions, such as certain single-gene disorders. The availability and scope of NIPT may vary based on local regulations and healthcare practices. It is recommended to consult with a healthcare provider or genetic counselor to understand the specific details and limitations of NIPT in your region.
- Fully validated algorithm
- Compatible with most library prep kits- we can help build the protocol
- Fully walk away informatics with LIMS integration
- On the fly baseline development for microdeletion testing as needed
- Upcoming support for single gene disorders